A detailed history of Easterly Investment Partners LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Easterly Investment Partners LLC holds 134,484 shares of PCRX stock, worth $2.62 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
134,484
Previous 105,556 27.41%
Holding current value
$2.62 Million
Previous $3.02 Million 32.92%
% of portfolio
0.17%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$11.7 - $28.46 $338,457 - $823,290
28,928 Added 27.41%
134,484 $2.03 Million
Q2 2024

Jul 25, 2024

BUY
$25.5 - $31.51 $668,992 - $826,664
26,235 Added 33.07%
105,556 $3.02 Million
Q1 2024

May 03, 2024

BUY
$27.7 - $35.48 $661,392 - $847,155
23,877 Added 43.07%
79,321 $2.32 Million
Q4 2023

Feb 14, 2024

BUY
$26.32 - $34.31 $463,074 - $603,650
17,594 Added 46.48%
55,444 $1.87 Million
Q3 2023

Nov 13, 2023

BUY
$30.68 - $40.09 $1.16 Million - $1.52 Million
37,850 New
37,850 $1.16 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Easterly Investment Partners LLC Portfolio

Follow Easterly Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Easterly Investment Partners LLC with notifications on news.